Federal Circuit Rules For Shwarz Pharma In Suit Over Univasc Patent
The U.S. Court of Appeals for the Federal Circuit has vacated a lower court's decision that supported Israeli generics maker Teva's right to sell a generic form of Schwarz Pharma's hypertension...To view the full article, register now.
Already a subscriber? Click here to view full article